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Edited by Sandro SonninoAbstract In human brain the Ab peptide is produced mainly by
neurons and the overexpression of amyloid precursor protein
(APP) that involves an increase in Ab secretion, has been
observed in some areas of the Alzheimer’s disease patients brain.
We have generated two stably transfected human neuroblastoma
lines which overexpress APP; both of them secreted Ab and
showed morphological changes and cell death with apoptotic
program characteristics. Interestingly, coculture experiments
with the untransfected human neuroblastoma cell line showed
that the Ab peptide was not responsible for the death in those cell
lines; additionally, we indicate that upon cell death, Ab peptide is
secreted into cell medium.
 2004 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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Alzheimer’s disease (AD) is characterized by a massive
neuronal death, and two typical hallmarks in the brain of the
patients are neuroﬁbrillary tangles and senile plaques. The
beta amyloid (Ab), the major constituent of the amyloid core
of senile plaques, is a 39–43 amino acid peptide produced
from a larger precursor, the amyloid precursor protein (APP)
[1]. The APP isoform with 695 amino acids (APP695) is the
most abundant in human brain and it is expressed in a high
amount in post-mitotic neurons during early periods of their
diﬀerentiation [2].
Several mutations in APP and presenilins segregate with
inherited AD forms of early onset familial AD or FAD [3].
Most of these mutations are located within or near the Ab
sequence, result in increased Ab production [4] and have been
associated with an increased vulnerability to cell death [5].
The correlation between APP mutations, amyloid deposits
and neurodegeneration led to the idea that modiﬁcation of* Corresponding author. Fax: +34-1-497-4870.
E-mail address: fvaldivieso@cbm.uam.es (F. Valdivieso).
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Abbreviations: APP, amyloid precursor protein; Ab, beta amyloid;
PSEN, presenilin; PARP-1, Poli (ADP-ribose) polimerase 1; AD,
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the evolution of AD. The neurotoxic eﬀects of Ab have been
essentially studied in vitro by treating neurons with high
concentrations of synthetic Ab peptide which result in oxida-
tive stress and cell death [6].
Here, we report the generation of a human neuroblastoma
cellular lines of cholinergic origin (SKNMC) that stably ex-
press high quantities of the APP isoform 695 and also secrete
Ab. We show evidence the APP overexpression in SKNMC
induces apoptosis, but the secreted Ab would not be respon-
sible for the death of those lines.2. Materials and methods
2.1. Cell culture and transfection
The SKNMC human neuroblastoma cell line (HTB10) was pur-
chased from the American Type Culture Collection. Cells were
transfected with pREP4-APP695 (kindly provided by Esperanza
Morato) or with empty vector using coprecipitation with calcium
phosphate [7]. Transfected APP-SKNMC cell lines (C2, C3) and the
vector-transfected cell line (C1-) were cultured in MEM (Life Tech-
nologies, Paisley, UK) supplemented with 10% heat-inactivated fetal
calf serum (FCS), 100 mU/ml penicillin G and 100 lg/ml streptomycin
and 0.16 mg/ml hygromycin B at 37 C in a humidiﬁed atmosphere of
95% air and 5% CO2.
2.2. Coculture of cellular lines
Coculture experiments were performed in a Transwell system
(Costar), that allows to incubate two diﬀerent cultures physically
separated through a porous membrane but sharing the culture me-
dium. Seventy two hours before each experiment, cells were seeded in
multiwell 6 well (M-6) coculture plates, at a density of 50 000 cell/cm2
for the lower and upper wells.
2.3. Conditioned medium preparation
The growth medium was replaced with fresh medium and cells were
incubated for 1, 4 or 7 days after which the supernatants were har-
vested, centrifuged and 10 concentrated in presence of a protease
inhibitors (2.5 mM EDTA, 10 lM leupeptin, 1 lM peptastin, 1 mM
phenylmethylsulfonyl ﬂuoride) cocktail using Centricon (Amicon) with
a cut-oﬀ value of 3 kDa. The conditioned medium supernatants were
stored at )70 C until sandwich ELISA analysis.
2.4. Ab detection by sandwich ELISA
We use the monoclonal antibody 6E10 (Signet), speciﬁc for amino
acids 1–17 of Ab as the capture antibody, and antibodies speciﬁc for
Ab 1–40 or 1–42 as detection antibodies (Biosource International).
Standard curves of synthetic peptides Ab 1–40 and Ab 1–42 (Biosource
International) were prepared in the same medium as samples. Under
these conditions, ELISA accurately detected Ab levels of 15 pg/ml or
greater.
The 6E10 was coated at 10 lg/ml into 96-well immunoassay plates
(Nunclon Maxisorp), overnight at 4 C. Then, plates were blockedation of European Biochemical Societies.
Fig. 1. Overexpression of human APP in SKNMC cell lines (C2, C3)
stably transfected with pREP4-APP695. (A) Western blot showing
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at 37 C. They were washed with 0.05% Tween 20 in PBS (PBST).
Samples and standards (50 ll/well) were added to plates and incubated
at room temperature (RT) for 2 h. Plates were washed three times with
PBST between each assay step.
Anti Ab 1–40 or anti Ab 1–42, diluted to 1 lg/ml with 1% BSA in
PBST, was incubated in wells for 1 h at RT. Secondary antibody
(anti-rabbit/goat horseradish peroxidase conjugate, Nordic) diluted
1/1000 with 1% BSA in PBST, was added to wells for 30 min at RT.
The assay was developed with 1 mg/ml of orto-phenylendiamine
(OPD) in phosphate buﬀer pH 6.0 and 0.1% H2O2. Optical densities
at 450 nm were measured using a spectrophotometric plate reader
(Dynatech).
2.5. Cell viability analysis
Cells were seeded on 96-multiwell plates 72 h before beginning in-
cubations at 37 C in an atmosphere humidiﬁed with CO2 to 7%.
The 3-(4, 5-dimethyl-thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide
assay. The extent of cell death was evaluated using the 3-(4, 5-di-
methyl-thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) assay
[8]. After culture times cells were incubated with 0.5 mg/ml MTT for 3
h at 37 C. MTT/formazan was extracted by overnight incubation at
37 C with 100 ll extraction buﬀer [20% sodium dodecyl sulphate
(SDS), 50% formamide adjusted to pH 4.7 with 0.02% acetic acid and
0.025 N HCl]. Optical densities at 570 nm were measured using a
spectrophotometric plate reader (Dynatech).
Release assay of the enzyme lactate dehydrogenase. The cell viability
assessed by determining the lactate dehydrogenase (LDH) into the
culture medium indicates loss of membrane integrity and cell death.
The LDH enzyme activity was measured with a commercial kit, Cy-
toTox 96 Non-Radioactive Cytotoxicity Assay (Promega), following
the manufacture instructions. Optical densities at 490 nm were mea-
sured using a spectrophotometric plate reader (Dynatech).
2.6. Western blotting
Cell lysates were analyzed by Western blot as previously described
[9]. Brieﬂy, RIPA extracted cell lysates (20 lg determined by Bradford
assay) were subjected to 8% SDS–PAGE. After electrophoresis, pro-
teins were transferred to nitrocellulose membranes (BioRad). Non-
speciﬁc reactivity was blocked by overnight incubation at 4 C with 3%
BSA/0.2% Tween-20 in PBS. Membranes were further processed by
incubating with primary antibodies for 2 h at room temperature, fol-
lowed by incubation with secondary antibodies (anti-mouse horse-
radish peroxidase conjugate, Vector Laboratories) and ﬁnally, band
visualization of using the enhanced chemilumininescence Western-
blotting analysis system (Pharmacia Biotech). The primary antibodies
used were monoclonal anti-APP antibody, MAB348 (Chemicon In-
ternational, Inc.) and monoclonal anti-PARP antibody (PharMingen
International). For internal control, levels of a-tubulin (anti-alpha-
tubulin, Sigma) were examined on the same blot.
2.7. Immunocytochemistry
Cells grown on coverslips were ﬁxed with 4% paraformaldehyde in
PBS at room temperature for 20 min and permeabilized with PBS
containing 0.2% Triton X-100 and 2% horse serum at 4 C overnight.
Cells were incubated at RT for 3 h with primary antibody (anti-APP,
MAB348). Later, cells were incubated at RT for 1 h with biotinilated
anti-mouse (Vector Laboratories) followed of the incubation with
ﬂuorescein avidin-D (Vector) at room temperature for 30 min. For
nuclei staining, coverslips were incubated in PBS containing 5 lg/ml
DAPI (Sigma) at for 15 min. Reactive images were observed by ﬂuo-
rescence microscopy (BX 51, Olympus).
2.8. Statistics
Results are expressed as means the standard error (S.E.) and
statistical diﬀerences were determined by Student’s two-tailed unpaired
t-test.APP expression in C2 and C3 (SKNMC cell lines stably transfected
with pREP4-695), C1- (SKNMC cell line stably transfected with
pREP4 vector) and SKNMC. (B) Quantiﬁcation by densitometry of
APP expression. Bars indicate fold expression referred to the APP
expression in SKNMC and normalized with a-tubulin. Values are gi-
ven as meansS.E. from three independent experiments (*, P < 0:05).
(C) Immunoﬂuorescence for APP of C2, C3, C1- and SKNMC cell
lines.3. Results
We have generated cellular lines of SKNMC human neu-
roblastoma that stably overexpress the APP protein with the
purpose of analizing, in a human neuronal model, the corre-lation between Ab production and the neuronal death. We
stably transfected the SKNMC cell line with an expression
vector (pREP4) which contains the APP695 cDNA, and we
have established two cell lines (C2 and C3) with APP overex-
pression; the same neuroblastoma transfected with pREP4,
without the insert, was used as control culture (C1-). We have
characterized the APP overexpression of C2 and C3 lines
as well as the integrity of the overexpressed protein, using
Western blot assay (Fig. 1(A)) with the anti-APP MAB348
antibody. The quantiﬁcation by densitometry revealed over-
expression levels of 6 and 1.5 times for C2 and C3, respectively,
with respect to SKNMC (Fig. 1(B)). The cytoplasmic pattern
for APP observed by immunoﬂuorescence for C2 and C3 lines
(Fig. 1(C)), is according with its physiologic localization [10];
SKNMC and C1- cultures, that only express the endogenous
APP protein, hardly show label of APP.
We subsequently quantiﬁed the two main species of amyloid
peptide, Ab 1–40 and Ab 1–42, using a ‘‘sandwich’’ ELISA
assay. As it is observed in the Fig. 2 (panels A and B) the C2
cell line that express higher APP levels, is also the line that
secretes more Ab peptide. Ab concentration was of 2500 pg/ml
(600 pM) for Ab 1–40 at 24 h after platting the cells, reaching
to a plateau of 4100 pg/ml (1000 pM) at 72 h; Ab 1–42 is
not detectable until 48 h, and it reaches a concentration of
Fig. 2. Kinetics of Ab secretion in SK-N-MC, C1-, C2 and C3 cellular
lines. Quantiﬁcation by sandwich ELISA speciﬁc for each one of Ab
species (Ab 1–40 and Ab 1–42) present in the culture medium
(meanS.E., n ¼ 3), at the indicated culture times.
Fig. 3. Apoptosis in the C2 and C3 cellular lines. (A) Representative
images of nuclear morphology analysis (DAPI) staining of the diﬀerent
cellular lines. The nuclear shape of apoptotic cells is indicated. Scale
bar¼ 20 lm. (B) Quantiﬁcation of the morphological analysis. For
each cell culture, 6 ﬁelds of 3 independent cultures were analyzed.
Results are given as the percentage of apoptotic nuclei per ﬁeld
(***P < 0:001). (C) Representative Western blot shows the degrada-
tion of the PARP-1. The arrows indicate the bands corresponding to
the protein PARP-1 without degrading (116 kDa) and to the fragment
of 85 kDa resulting of its proteolysis. In the inferior panel, the arrow
indicates the band corresponding to the a-tubulina.
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line produces levels of secreted Ab 1–40 much lower (100 pg/
ml: 20 pM), than the C2 cell line; and Ab 1–42 is not detectable
at none of the assayed times. SKNMC and C1- lines did not
produce detectable levels of secreted Ab 1–40 or Ab 1–42.
During the cellular lines characterization we found C2 cell
line presented a morphological changes series (data not
shown), among those a greater neurite extension, greater cel-
lular volume and greater adhesion to the culture plate, as well
as a slower growth than SKNMC, C3 and C1- cell lines.
Likewise, C2 and C3 presented detectable cellular death that
did not present neither the SKNMC cellular line, nor the C1-
control line.
When we examined the nuclear morphology of SKNMC,
C1-, C2 and C3 lines using DAPI staining (Fig. 3, panels A
and B) we found C2 and, in smaller proportion, C3, presents a
signiﬁcant percentage of nuclei with condensed chromatin (C2:
7.28%, C3: 3.4%) compared with SKNMC and C1- (0.63% and
0.89% of apoptotic nuclei, respectively). The apoptotic pro-
gram involves a specialized cellular machinery which includes
the activation of caspases [11], and when we analized the
degradation of the caspase sustrate, poly (ADP-ribose) poly-
merase 1 (PARP-1), (Fig. 3(C)) both in C2 and C3 lines the
anti-PARP antibody revealed besides the band corresponding
to the whole PARP-1 protein (116 kDa), a band corresponding
to 85 kDa fragment resulting from PARP-1 degradation as
consequence of the activation of the apoptotic program. In
contrast, in SKNMC and C1- lines the proteolytic degradation
of PARP-1 was not detected. These results indicated a positivecorrelation among APP overexpression and the apoptotic
program activation of cellular death.
The synthetic Ab concentration necessary to produce cyto-
toxicity in SKNMC neuroblastoma (10 lM) (data not shown)
was several orders of magnitude higher than the Ab secreted
concentration by C2 (Ab 1–40: 1 nM; Ab 1–42: 400 pM) and
C3 (Ab 1–40: 20 pM). This result suggest that the lack of ac-
tion of Ab on untransfected SKNMC cells is not due to a
problem at the cell receptor level, but simply, of Ab concen-
tration. On the other hand, Ab levels secreted by C2 line were
the same order of magnitude than the physiological Ab con-
centration in cerebrospinal liquid [12]. With the purpose of
studying if the Ab secreted by C2 cells produced cell death in
SKNMC we performed coculture experiments after checking
the ‘‘Transwell’’ system did not aﬀect Ab levels secreted by
C2 (data not shown). When we analyzed the viability of lines
C2, C1- and SKNMC in the diﬀerent cocultures, although the
loss of viability of C2 was 30% approximately respect to un-
transfected cells (Fig. 4(A)), we observed that the viability of
SKNMC was not aﬀected by coculturing it with C2. Addi-
tionally, the proteolytic degradation of PARP-1 was observed
in C2 line, but not in SKNMC line cocultured in presence of
C2 or C1- (Fig. 4(B)).
Therefore, our results indicated that Ab peptide secreted by
the stable cellular line overexpressing APP (C2) does not seem
to be the responsible of the basal death which presents this
neuroblastoma, and the death of C2 and C3 lines could take
place as consequence of APP overexpression.
Fig. 4. The Ab secreted by the C2 cell line does not produce cell death in the SKNMC neuroblastoma. The SK-N-MC, C2 and C1- cell lines were
cocultured in the system ‘‘Transwell’’ and seeded in the upper or lower well. (A) Cell viability measured by MTT assay and normalized with the LDH
activity. Results (mean S.E.) are given as the percentage of viability as compared with the SKNMC control culture (*P < 0:05, n ¼ 3). (B)
Degradation of the PARP-1 analyzed by Western blot.
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All mutations in APP, PSEN1 and PSEN2 genes associated
to familial forms of AD increase the production of Ab [13].
These observations and the broadly reported neurotoxic Ab
peptide eﬀect [14] led to formulate the already classic amyloi-
dogenic theory of AD [15], according to which, Ab peptide
plays an early and central role in the pathogenesis of AD.
Although the APP amyloidogenic processing is majority in
neurons [16], most of studies have been carried out in non-
neuronal cultures [17] and, in murine neuronal cultures [18];
possibly due to the diﬃculty to obtain stably transfected
human neuroblastoma cellular lines [19]. In this context, we
decided to generate lines of SKNMC human neuroblastoma
which overexpress in a stable way the 695 isoform of APP
protein (C2 and C3 lines) and to analyze Ab production in
these human neuronal lines. Although both lines produced
Ab 1–40, we found only the line which expressed high APP
levels (C2) secreted also Ab 1–42. These results were co-
herent with those published indicating the majoritary species
(90%) are 40 amino acids, both in healthy individuals and in
AD patients [12]. Ab concentration secreted by our C2 line
(Ab 1–40: 1000 pM, Ab 1–42: 400 pM) is greater than the
ones reported for other neuronal models which express hu-
man APP695 (Ab 1–40: 7–25 pM, Ab 1–42: non-detectable;
[17,20]) and similar to that observed in cultures of hamster
CHO cellular line stably transfected with APP695 (Ab 1–40:
807 pM, Ab 1–42: 11.8 pM; [17]). Likewise, Ab concentra-
tion secreted by our C2 line is in the same magnitude order
than in the cerebrospinal ﬂuid of healthy individuals and AD
patients [12].
The morphological changes observed, during the charac-
terization of our cellular lines of SKNMC human, are con-
sistent with some of the functions assigned to APP, like the
cell–cell [21] and cell–extracellular matrix adhesion [22], as well
as the role in the regulation of the neurite growth and exten-
sion [21]. Likewise, C2 and C3 lines presented some cellular
death levels that do not present neither SKNMC, nor the
C1- control line. We found proteolytic degradation of PARP-1protein in C2 and C3 cellular lines that demonstrated a posi-
tive correlation among APP overexpression, Ab production
and cellular death. Our results are consistent with the in-
volvement of caspases in Ab peptide formation [23], and with
data published showing that APP overexpression in rat hip-
pocampal neurons produce their apoptotic degeneration in
vitro and in vivo [24,25], in a process that implies caspase 3
activation.
With the purpose of checking the secreted Ab peptide role
in the death of our cellular lines, we carried out coculture
experiments, and we found Ab secreted by C2 line did not
aﬀect the cellular viability of SKNMC line. In this sense, it
has been described the rat neuronal culture treatment with
culture medium – that contains diﬀerent quantities of Ab 1–
40/Ab 1–42 – coming from cells that overexpress APP does
not aﬀect the viability of the cultures, although these authors
attribute the death observed in the rat neuronal cultures that
overexpress APP to the production of intracelular Ab [17,20].
However, we did not detect intracellular Ab in C2 and C3
lines (data not shown) making improbable the death observed
in our cellular lines are due to accumulation of intracellular
Ab.
Along this work, we have described Ab peptide secreted by
SKNMC human neuroblastoma cell lines that overexpress
APP in a stable way would not be responsible for the death
that these cells present, but however APP overexpression could
produce the death, and rises the concentration of secreted Ab
as a consequence.
In summary, our results indicate, in a human neural cell
model, that APP overexpression induces the apoptotic death of
neurons accompanied by the secretion of Ab 1–40 and Ab 1–42
species; that in turn seem not to be able of inducing the death
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